CD8A and B-cell chronic lymphocytic leukemia: Interestingly, a distinct role for TIGIT has been suggested in both solid and hematological tumors, as demonstrated by its high expression on CD4+ but not CD8+ T cells in chronic lymphocytic leukemia (CLL) [198].